Latest Market Competition News

The Federal Court of Australia has approved the acquisition of NSX Limited by a related entity of the Canadian Securities Exchange operator, setting the stage for NSX’s delisting from the ASX later this month.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

Elders Limited has secured regulatory approval to acquire Delta Agribusiness, subject to divesting six Western Australian branches, while maintaining a positive outlook for FY25 earnings.

Pro Medicus Limited’s European arm, Visage Imaging, has landed a significant five-year, A$10 million contract to supply next-generation imaging technology to University Hospital Heidelberg and the German Cancer Research Institute, marking a strategic expansion in Europe.

333D Limited has confirmed a $1 million placement to fund significant upgrades to its digital asset management platform, explaining a recent sharp rise in its share price and trading volume.

The ACCC has raised preliminary concerns that IAG’s proposed acquisition of RAC Insurance in Western Australia could reduce competition, potentially leading to higher premiums and limited repair service access for rivals.

archTIS Limited has opened the retail component of a $17 million entitlement offer to support its acquisition of Spirion LLC’s assets, aiming to expand its US footprint and enhance its cybersecurity product suite.

OD6 Metals announces a major upgrade at its Splinter Rock Rare Earth Project with the addition of an onsite Chlor-Alkali Facility, promising significant cost savings and enhanced product flexibility. This development could reshape the economics and sustainability profile of one of Australia’s largest rare earth deposits.

Jcurve Solutions Limited reported a significant turnaround in FY25 with a Normalised EBITDA profit and a narrowed net loss, despite an 11% revenue decline. The company also strengthened its Asia presence through acquisition and boosted liquidity with a $1 million capital raise.

Maggie Beer Holdings reported a $24.3 million statutory loss for FY25 but showed promising sales growth and significant cost savings as it restructures for profitability.

Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.

BTC Health reports a strong FY25 with a $4 million statutory profit, boosted by a $5 million contract and strategic acquisition. The company eyes further growth in FY26 with new product launches and expanded market reach.